Answers are grounded in this paper and cite their sources.
Electrospun nanofibers are promising carriers for drug delivery owing to their high surface-are-to-volume ratio, high porosity, tunable architecture, and capacity for efficient drug incorporation. This review provides a comprehensive analysis of electrospinning as a fabrication technique for polymeric drug delivery systems, linking fabrication parameters, fiber morphology, drug incorporation strategies, and drug release profiles that are usually discussed separately. The influence of the solution, process, and environmental parameters on fiber characteristics is discussed, highlighting their role in determining drug loading efficiency and release kinetics. Different drug incorporation strategies, including surface adsorption, blend, emulsion, and coaxial electrospinning were compared. Then, polymers commonly used in electrospun drug delivery systems (DDSs) were reviewed. Representative biomedical applications of electrospun DDSs include wound healing, prevention of implant-associated infections, transdermal delivery, and local cancer therapy. Despite significant advances, widespread clinical translation is limited by the burst release, poor reproducibility, residual solvents, the effects of sterilization, storage instability, a low production rate, and the lack of standardized quality-control and release-testing methods. Addressing these challenges through rational material selection, optimized fiber design, scalable manufacturing approaches, and rigorous preclinical and clinical validation will be essential for the successful implementation of electrospun nanofiber-based drug delivery systems in clinical practice.
No takes yet. Share an insight, caveat, or question.
Szymaszek et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: